193 related articles for article (PubMed ID: 35785172)
1. Risk Factors for Anthracycline-Induced Cardiotoxicity in Breast Cancer Treatment: A Meta-Analysis.
Zhang M; Yang H; Xu C; Jin F; Zheng A
Front Oncol; 2022; 12():899782. PubMed ID: 35785172
[TBL] [Abstract][Full Text] [Related]
2. Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.
Obasi M; Abovich A; Vo JB; Gao Y; Papatheodorou SI; Nohria A; Asnani A; Partridge AH
Cancer Causes Control; 2021 Dec; 32(12):1395-1405. PubMed ID: 34406595
[TBL] [Abstract][Full Text] [Related]
3. Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis.
Jin H; Xu J; Sui Z; Wang L
Front Cardiovasc Med; 2023; 10():1101585. PubMed ID: 36742068
[TBL] [Abstract][Full Text] [Related]
4. Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis.
Alizadehasl A; Ghadimi N; Kaveh S; Maleki M; Ghavamzadeh A; Noohi F; Hosseinifard H
Int J Clin Pharm; 2021 Feb; 43(1):25-34. PubMed ID: 32910372
[TBL] [Abstract][Full Text] [Related]
5. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.
Kaboré EG; Guenancia C; Vaz-Luis I; Di Meglio A; Pistilli B; Coutant C; Cottu P; Lesur A; Petit T; Dalenc F; Rouanet P; Arnaud A; Arsene O; Ibrahim M; Wassermann J; Boileau-Jolimoy G; Martin AL; Lemonnier J; André F; Arveux P
PLoS Med; 2019 Dec; 16(12):e1002989. PubMed ID: 31869400
[TBL] [Abstract][Full Text] [Related]
6. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis.
Yamaguchi N; Fujii T; Aoi S; Kozuch PS; Hortobagyi GN; Blum RH
Eur J Cancer; 2015 Nov; 51(16):2314-20. PubMed ID: 26343314
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study of genetic variants related to anthracycline-induced cardiotoxicity in early breast cancer.
Park B; Sim SH; Lee KS; Kim HJ; Park IH
Cancer Sci; 2020 Jul; 111(7):2579-2587. PubMed ID: 32378780
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer.
Macedo AVS; Hajjar LA; Lyon AR; Nascimento BR; Putzu A; Rossi L; Costa RB; Landoni G; Nogueira-Rodrigues A; Ribeiro ALP
JACC CardioOncol; 2019 Sep; 1(1):68-79. PubMed ID: 34396164
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle factors of smoking, BMI and alcohol on the risk of Non-Melanoma Skin Cancer in adults: a systematic review.
Leonardi-Bee J; Ellison T; Bath-Hextall F
JBI Libr Syst Rev; 2012; 10(6):352-398. PubMed ID: 27820578
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
Henry ML; Niu J; Zhang N; Giordano SH; Chavez-MacGregor M
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1084-1093. PubMed ID: 30092967
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline Chemotherapy-Induced Cardiotoxicity in Breast Cancer Survivors: A Systematic Review.
Lin KJ; Lengacher CA
Oncol Nurs Forum; 2019 Sep; 46(5):E145-E158. PubMed ID: 31424455
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials.
Smith LA; Cornelius VR; Plummer CJ; Levitt G; Verrill M; Canney P; Jones A
BMC Cancer; 2010 Jun; 10():337. PubMed ID: 20587042
[TBL] [Abstract][Full Text] [Related]
14. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.
van Dalen EC; van der Pal HJ; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2006 Oct; (4):CD005008. PubMed ID: 17054232
[TBL] [Abstract][Full Text] [Related]
15. The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines ± Trastuzumab: a Meta-analysis of clinical studies.
Elghazawy H; Venkatesulu BP; Verma V; Pushparaji B; Monlezun DJ; Marmagkiolis K; Iliescu CA
Crit Rev Oncol Hematol; 2020 Sep; 153():103006. PubMed ID: 32777728
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of ACEI/ARB on Left Ventricular Function in Anthracycline-Induced Chronic Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials.
Lin H; Liang G; Wu Y; Chen L
Cardiology; 2021; 146(4):469-480. PubMed ID: 33946067
[TBL] [Abstract][Full Text] [Related]
17. Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis.
Koulaouzidis G; Yung AE; Yung DE; Skonieczna-Żydecka K; Marlicz W; Koulaouzidis A; Charisopoulou D
Curr Probl Cancer; 2021 Oct; 45(5):100723. PubMed ID: 33726923
[TBL] [Abstract][Full Text] [Related]
18. microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis.
Pereira JD; Tosatti JAG; Simões R; Luizon MR; Gomes KB; Alves MT
Biomed Pharmacother; 2020 Nov; 131():110709. PubMed ID: 32937248
[TBL] [Abstract][Full Text] [Related]
19. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
[TBL] [Abstract][Full Text] [Related]
20. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]